COMMUNIQUÉS West-GlobeNewswire

Raleigh Radiology selects Client Outlook as Vendor of Choice for Integrated Clinical and Diagnostic Viewing

27/11/2018 - 15:00

WATERLOO, Ontario, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA Class II enterprise diagnostic and clinical image viewing solutions, announced today it has been selected as the vendor of [...]

Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer

27/11/2018 - 15:00

GAITHERSBURG, Md., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced the appointment of Vipin K. Garg, Ph.D. as its President and Chief [...]

Predictive Technology Group to Present at 11th Annual LD Micro Main Event Conference on December 4

27/11/2018 - 15:00

SALT LAKE CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, announces that Bradley Robinson, President and CEO, will present a corporate [...]

OrthoPediatrics Corp. Enhances Product Offering with Upgraded PediLoc® Femur Plate System

27/11/2018 - 15:00

WARSAW, Ind., Nov. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the U.S. launch of its new PediLoc® [...]

Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclusive Pilot Program For ilumen™

27/11/2018 - 15:00

SYDNEY, Australia and MINNEAPOLIS, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement [...]

Publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease

27/11/2018 - 14:51

Orphazyme A/S Investor news No. 14/2018 Company Registration No. 32266355 Copenhagen, November 27, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]

Marrone Bio Innovations, Inc. to Present at 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th

27/11/2018 - 14:31

DAVIS, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]

How Dual Listings Are Helping Cannabis Companies Access Capital -- CFN Media

27/11/2018 - 14:30

SEATTLE, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Psoria-Shield, Inc. and Neo Phototherapy LLC Developing Next Generation LED Phototherapy Device

27/11/2018 - 14:30

HOFFMAN ESTATES, IL, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Wellness Center USA, Inc. (OTCQB: WCUI) and Psoria-Shield, Inc. (PSI) today announced the formation of a Joint Venture between Psoria-Shield, Inc [...]

FSD Pharma’s New CEO is a Top GW Pharma Executive -- CFN Media

27/11/2018 - 14:30

SEATTLE, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Atara Biotherapeutics to Host CAR T Breakfast Teach-In on November 29, 2018

27/11/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]

Orion Corporation: Managers' transactions - Mikael Silvennoinen

27/11/2018 - 14:15

ORION CORPORATION MANAGERS' TRANSACTIONS 27 November 2018 at 15.15 EET Orion Corporation: Managers' transactions - Mikael Silvennoinen Orion Corporation has received the following disclosure under Market Abuse [...]

Cognition Therapeutics Expands Industry-Leading Expertise in Research and Clinical Use of Biomarkers of Alzheimer’s Disease

27/11/2018 - 14:03

Drs. Kaj Blennow, John Harrison and Henrik Zetterberg Join Medical Advisory Board Pittsburgh, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the [...]

FIT Biotech Oy: EHVA starts recruiting participants to clinical trial testing FIT Biotech's vaccine

27/11/2018 - 14:01

FIT Biotech Oy Company release 27.11.2018 at 03:00 PM EET EHVA starts recruiting participants to clinical trial testing FIT Biotech's vaccine European EHVA-vaccine alliance (European HIV Vaccine Alliance, EHVA) starts [...]

BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies

27/11/2018 - 14:00

Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Sera Prognostics Completes Enrollment of Large, Multicenter, Prospective Clinical Study of PreTRM® Test

27/11/2018 - 14:00

TREETOP Study will Explore Enhancements to Sera’s Validated PreTRM ® Test SALT LAKE CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, announced today that it has completed [...]

PhaseBio Announces Dosing of First Patient in Phase 2b Clinical Trial of PB1046 in Pulmonary Arterial Hypertension

27/11/2018 - 14:00

MALVERN, Pa. and SAN DIEGO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]

electroCore Expands Manufacturing Capabilities for gammaCore™

27/11/2018 - 14:00

BASKING RIDGE, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced expansion into a new design and development [...]

Paratek Pharmaceuticals Doses First Patient in Phase 2 Clinical Trial of Omadacycline in Acute Pyelonephritis, a Common Subset of Complicated Urinary Tract Infections

27/11/2018 - 14:00

BOSTON, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]